Medicine Grand Rounds- Dr. Sascha Tuchman presents: “Nimbly Bounding Over the Hills? Multiple Myeloma in 2024.”

Dr. Tuchman is an expert in managing patients with multiple myeloma, amyloidosis, and other plasma cell disorders. His clinical research focuses on treating multiple myeloma in patients who are at high risk for toxicity due to advanced age or other medical problems; developing novel drugs for treating all patients with multiple myeloma; and optimizing management for amyloidosis. Here at UNC, he leads the clinical and research multiple myeloma and amyloidosis program, as well as serving in a number of administrative and research oversight roles.  He is a member of international myeloma and amyloidosis working groups that formulate guidelines for treating these disorders, and his research has been funded by NIH, pharma partners, and private philanthropic organizations.